Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?

Current therapy directed at delaying the progression of diabetic nephropathy includes intensive glycemic and optimal blood pressure control, renin angiotensin-aldosterone system blockade and multifactorial intervention. However, the renal protection provided by these therapeutic modalities is incomp...

Descripción completa

Detalles Bibliográficos
Autores principales: Górriz, Jose Luis, Nieto, Javier, Navarro-González, Juan F., Molina, Pablo, Martínez-Castelao, Alberto, Pallardó, Luis M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626660/
https://www.ncbi.nlm.nih.gov/pubmed/26512703
http://dx.doi.org/10.3390/jcm4101866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626660/
https://www.ncbi.nlm.nih.gov/pubmed/26512703
http://dx.doi.org/10.3390/jcm4101866

Ejemplares similares